Depressant fluvoxamine not effective in reducing COVID inflammation--study

Study shows no benefits of antidepressant for COVID-19 symptoms - UPI.com Researchers studied fluvoxamine because previous evidence suggested that it might be able to reduce inflammation caused by the virus. UPI

A clinical trial designed to test repurposed medications for their impact on fighting COVID-19 has found no benefit to taking the antidepressant fluvoxamine (Luvox) to ease coronavirus symptoms.